Drug Search Results
More Filters [+]

Indisetron

Alternative Names: indisetron
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Beijing Jialin Pharmaceutical Co., Ltd.
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Indisetron

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Other

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20170613

P2

Unknown Status

Other

None

CTR20170752

N/A

Not yet recruiting

Oncology Unspecified|Healthy Volunteers

None

Recent News Events

Date

Type

Title